Mercks 8 -billion dollar -Cancer -Cancer compared to the first US jury




The jury will weigh whether Merck has held back the side effect reports of pharmaceutical regulators and launched misleading marketing campaigns to transform the medication into a blockbuster product. Read more



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *